Mysimba Prolonged-release Tablets

prescription weight-loss medication combining naltrexone and bupropion, used with diet and exercise to help obese or overweight adults manage weight by reducing hunger and cravings by acting on brain pathways for appetite and reward. It's for those with a BMI ≥ 30, or ≥ 27 with weight-related issues like high blood pressure or diabetes, and is taken as a prolonged-release tablet, but doctors may stop treatment if insufficient weight loss (less than 5% in 16 weeks) occurs. Common side effects include nausea, constipation, headache, and insomnia, with serious risks like seizures for those predisposed, requiring medical supervision.